<DOC>
	<DOCNO>NCT00443105</DOCNO>
	<brief_summary>The purpose study determine efficacy , tolerance safety tacrolimus 0.03 % ointment treatment intractable allergic conjunctivitis .</brief_summary>
	<brief_title>Topical Tacrolimus 0.03 % Ointment Intractable Allergic Conjunctivitis : An Open Label Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Subjects include &gt; 5 year old suffer intractable allergic conjunctivitis pregnancy breastfeeding , history herpetic eye disease , transplant patient concomitant administration drug inhibit cytochrome CYP3A4 , hypersensitivity macrolides</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>